PRRT (Peptide Receptor Radionuclide Therapy)
BELFAST HEALTH AND SOCIAL CARE TRUSTcontractFind a Tender ↗Ref ocds-h6vhtk-05dd8bProcurement Act 2023pending
Estimated value
—
Awarded value
£1.8m
Awarded 10 Nov 2025
Suppliers
1
Lots
1
1 awarded
Published
10 Nov 2025
Other contracts from BELFAST HEALTH AND SOCIAL CARE TRUST· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Promotional Products and Stands | contract | £4.1m | 09 Apr 2026 |
| Maintenance of LithoClast Trilogly | contract | £199k | 27 Mar 2026 |
| BHSCT Maintenance of Agilent Laboratory Equipment | contract | £317k | 27 Mar 2026 |
| Maintenance of Generator Sets including Alternators, Control Systems, Local and Remote ACB Switching Controls | contract | £12.9m | 05 Mar 2026 |
| Total Cellular Pathology Solution - 2805386 | contract | — | 04 Mar 2026 |
| Urine, Cerebrospinal Fluid (CSF) and body fluids microscopy analyser(s), consumables, reagents and Quality Control | contract | £1.4m | 04 Mar 2026 |
| Promotional Products and Stands | contract | £4.6m | 03 Mar 2026 |
| Spinal, Blood Collection Needles and Associated Products | contract | £7.9m | 27 Feb 2026 |
| Primary Packaging for the Disposal of Clinical Waste | contract | £10.5m | 16 Feb 2026 |
| Pest Control Services | contract | — | 21 Jan 2026 |
Other contracts awarded to NOVARTIS PHARMACEUTICALS UK LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| TRAMETINIB 2MG TABLETS, 30 tablet, pack, PACK OF 1 | contract | — | 05 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 17 | contract | — | 12 Jan 2026 |
| NHS National Framework Agreement for Omalizumab | contract | — | 30 Dec 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 22 Dec 2025 |
| Contract for Netspot (Gallium Ga 68 Dotatate) | contract | — | 08 Dec 2025 |
| NHS National Framework Agreement for Omalizumab | contract | — | 28 Nov 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 11 Nov 2025 |
| SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection | contract | — | 10 Nov 2025 |
| Transitional Drugs 4 | contract | — | 05 Sept 2025 |